Explore News By Topic

07/23/2019

Gene test picks out prostate cancer patients who could benefit from ‘search-and-destroy’ medicine

Original Press Release Issued by: The Institute of Cancer Research, London Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports. An emerging class of drugs are made up of a radioactive particle that... Read More

06/12/2019

New Class of Life-Extending Drugs for Men with Metastatic Hormone-Sensitive Prostate Cancer

At the 2019 American Society of Clinical Oncology (ACSO) Annual Meeting, results presented by two PCF-funded investigators from pivotal phase 3 clinical trials will likely lead to approval of a new class of life-extending treatment options for men with metastatic hormone-sensitive prostate cancer (mHSPC). mHSPC refers to men whose prostate... Read More

05/30/2019

THE PROSTATE CANCER FOUNDATION AND MAJOR LEAGUE BASEBALL KICK OFF 24th ANNUAL HOME RUN CHALLENGE ON JUNE 1st

One in 9 U.S. men will be diagnosed with prostate cancer which is equivalent to at least one player on a baseball team One man dies from prostate cancer every 17 minutes which is roughly equivalent to one player per inning More than 31,000 men will die from prostate cancer... Read More

05/22/2019

Black men less likely than nonblack patients to adopt active surveillance for low-risk prostate cancer

Original Press Release Issued by: Dana-Farber Cancer Institute Overall active surveillance rates are up, though the increase is significantly smaller for black patients Black men may be deterred by both socioeconomic factors and providers’ hesitation given concern for underlying aggressive disease BOSTON – At a time when a growing number of... Read More

05/21/2019

A New Standard of Care for Low-Volume Metastatic Prostate Cancer

Men diagnosed with metastatic prostate cancer will often not undergo local treatments of the primary prostate tumor, such as surgery or radiation. Primary hormone therapy (also known as androgen deprivation therapy or ADT) has long been the standard of care, although recently the addition of docetaxel or abiraterone to ADT... Read More

05/14/2019

Natural Killer Cells for Prostate Cancer Immunotherapy

Achoo! Caught a nasty cold from that co-worker who insisted on bringing her hacking cough to the office? No problem….your immune system will fight the invading virus and you’ll be feeling better in a few days. We’re used to thinking of the immune system as the body’s defense against colds,... Read More

05/08/2019

Prostate Cancer Foundation’s Robust Collection of New Patient Resources, Including New 2019 Prostate Cancer Patient Guide Now Available

- Updated Publication: Prostate Cancer Patient Guide - Updated Publication: Additional Facts for African-American Men and Their Families - New Online Tool: Prostate Cancer Clinical Trial Finder - New Article Series: Thoughts on Prostate Cancer by Janet Farrar Worthington - Online Support Groups: Facebook Communities for Patients, Caregivers and Survivors... Read More

05/06/2019

Gene mutation discovery linked to very poor survival in prostate cancer patients

Original Press Release Issued by: ICR (The Institute of Cancer Research) Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival – and which could be used to pick out patients for especially intensive treatment. Men with mutations in... Read More

04/01/2019

Prostate Cancer Foundation Ambassadors Harry Lennix, Chris Tucker, Randy Jackson, Rev. Rosey Grier, Brian Custer and Others Join Together to Raise Awareness About Prostate Cancer During National Minority Health Month

LOS ANGELES, Calif. – April 1, 2019 – The Prostate Cancer Foundation (PCF) today announced the kick-off of its new national “Know the Numbers” campaign to raise awareness about how prostate cancer disproportionately affects African American men, who are 76 percent more likely to be diagnosed than men of other... Read More

03/28/2019

Researchers Discover How a Gene Deletion Contributes to Prostate Cancer Growth

Original Press Release Issued by: Weill Cornell Medicine The deletion of a gene that normally promotes healthy cell division in the prostate encourages the growth of cancer in the gland, according to a new study by Weill Cornell Medicine investigators. The findings, published March 28 in Cancer Cell, suggest that... Read More